Skip to main content

Table 1 Clinical and pathological characteristics of samples

From: Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study

Parameters

Normal

BPM

EOC

Sample Size Na (%)

8 (14.5)

17 (30.5)

31 (55)

Age - Median (min - max)

61.5 (52–75)

58.0 (38–81)

60.0 (48–82)

BMI - Median (min - max)

30.7 (24.53–30.98)

28.00 (19.11–52.00)

29.3 (19.53–47.11)

Premenopausal N (%)b

2 (25)

7 (41)

2 (6)

Postmenopausal N (%)b

6 (75)

10 (59)

29 (94)

Obesity N (%)b

3 (38)

3 (18)

9 (29)

Diabetes N (%)b

3 (38)

3 (18)

5 (17)

Hyperlipidimia N (%)b

5 (63)

3 (18)

13 (41)

Hypertension N (%)b

4 (50)

7 (41)

7 (22)

Hypothyroidism N (%)b

4 (50)

4 (24)

4 (13)

FIGO stage - N (% of EOC)

 Stage I

8 (25.8)

 Stage II

4 (12.9)

 Stage III

17 (54.8)

 Stage IV

2 (6.5)

Histotype - N (% of EOC)

 Serous

24 (77.4)

 Mucinous

4 (12.9)

 Endometrioid

3 (9.7)

  1. BMI Body mass index, FIGO International Federation of Gynecology and Obstetrics, BPM Benign Pelvic Mass, EOC Epithelial ovarian cancer. Obesity is defined as BMI ≥ 30. a Indicates total number of patients eligible for the study. b Percentages are calculated within each study group